HAP Trading’s Bionano Genomics BNGO Stock Holding History

HAP Trading’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-77	Closed	-$269K	–	2448
2021 Q2	$337K	Sell	77 -23	-23%	-$90.8K	0.01%	789
2021 Q1	$486K	Buy	+100	New	+$564K	0.03%	494

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HAP Trading's BNGO Position: Q3 2021 in Review

HAP Trading sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 77 shares — an estimated $269K sold.

HAP Trading first reported a position in BNGO in Q1 2021 and held it in 2 quarters. The position peaked at $486K in Q1 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

HAP Trading reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
HAP Trading sold 77 Bionano Genomics shares in Q3 2021, an estimated $269K.
HAP Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 2 quarters.
HAP Trading's Bionano Genomics position peaked at $486K in Q1 2021.
147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.